MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
Phase 2
Recruiting
- Conditions
- Metastatic Penile Squamous Cell CarcinomaStage III Penile Cancer AJCC v8Stage IV Penile Cancer AJCC v8Unresectable Penile Squamous Cell Carcinoma
- Interventions
- Drug: Enfortumab VedotinProcedure: Computed TomographyProcedure: Magnetic Resonance Imaging
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 28
- Registration Number
- NCT06104618
- Locations
- 🇺🇸
Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic in Rochester, Rochester, Minnesota, United States
Qualitative Techniques to Define Meaningful Within-Patient Change in Symptoms of Advanced Cancer Patients
Completed
- Conditions
- Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
- Interventions
- Other: Non-Interventional Study
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT06104657
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
The Effect of Synaquell™ in Contact Sport Athletes
Not Applicable
Recruiting
- Conditions
- Healthy
- Interventions
- Dietary Supplement: Synaquell(TM)Dietary Supplement: Placebo
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 40
- Registration Number
- NCT06104670
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Study of Deucravacitinib to Treat LPP and FFA
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 12
- Registration Number
- NCT06091956
- Locations
- 🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic Florida, Jacksonville, Florida, United States
Adipose Tissue Blood Flow in Aging Humans
Not Applicable
Recruiting
- Conditions
- HealthyAging
- Interventions
- Other: 75 gm oral glucose load
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 24
- Registration Number
- NCT06096532
- Locations
- 🇺🇸
Mayo Clinic Minnesota, Rochester, Minnesota, United States
The TELENEO Trial: a Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
Not Applicable
Recruiting
- Conditions
- Death; NeonatalMorbidity;Newborn
- Interventions
- Other: Teleneonatology
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 947
- Registration Number
- NCT06087224
- Locations
- 🇨🇦
Stevenson Memorial Hospital, Alliston, Ontario, Canada
🇨🇦William Osler Health System - Brampton Civic Hospital, Brampton, Ontario, Canada
🇨🇦Michael Garron Hospital, East York, Ontario, Canada
Metabolic and Physiologic Responses to Hormone Therapy in Transgender and Gender Diverse People
Recruiting
- Conditions
- Effects of GAHT, on Skeletal Muscle in TGD
- Interventions
- Behavioral: hormone therapy
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 24
- Registration Number
- NCT06083766
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
Phase 2
Recruiting
- Conditions
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
- Interventions
- Procedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Endoscopic UltrasoundProcedure: EsophagogastroduodenoscopyRadiation: Hypofractionated Radiation TherapyProcedure: Positron Emission TomographyOther: Survey Administration
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 99
- Registration Number
- NCT06078709
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
🇺🇸Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
Lumbar Vein Embolization for Chronic Headaches with Nutcracker Physiology
Not Applicable
Recruiting
- Conditions
- Nutcracker Phenomenon, RenalNutcracker Syndrome, RenalChronic Headache
- Interventions
- Procedure: Coil Embolization of the Lumbar Vein
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 4
- Registration Number
- NCT06077747
- Locations
- 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Recruiting
- Conditions
- Metastatic Malignant Solid NeoplasmMetastatic MelanomaLocally Advanced MelanomaStage IV Lung Cancer AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8Locally Advanced Lung CarcinomaMetastatic Lung CarcinomaClinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Malignant Solid NeoplasmStage III Lung Cancer AJCC v8
- Interventions
- Procedure: Biospecimen CollectionOther: Electronic Health Record Review
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 500
- Registration Number
- NCT06075524
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath